How should I evaluate and manage a patient with suspected dengue fever?

Evaluation and Management of Suspected Dengue Fever

For patients presenting within 7 days of symptom onset, order dengue virus NAAT (RT-PCR) and NS1 antigen testing on serum as your primary diagnostic tests; for those presenting after 7 days, order IgM antibody testing instead. 1

Diagnostic Approach Based on Timing

Early Presentation (≤7 Days After Symptom Onset)

• Perform dengue virus NAAT (RT-PCR) on serum as the first-line test, as viral RNA remains detectable for 4-6 days after symptom onset and provides definitive confirmation of acute infection. 1, 2

• Add NS1 antigen testing simultaneously to enhance diagnostic sensitivity, since NS1 is detectable from day 1 through day 10 of illness, with peak sensitivity (75-90%) during days 3-5. 1, 3

• In regions where both dengue and Zika virus circulate, perform NAATs for both viruses simultaneously to differentiate between these flaviviruses, as cross-reactivity in antibody testing makes serologic differentiation unreliable. 4, 1

• Serum is the preferred specimen, though some NAATs can be performed on plasma, whole blood, cerebrospinal fluid, or urine. 4

Late Presentation (>7 Days After Symptom Onset)

• Order IgM capture ELISA (MAC-ELISA) as the primary diagnostic test when patients present more than 7 days after symptom onset, as IgM antibodies appear during the first week and persist for 2-3 months. 1, 3

• If both dengue and Zika virus IgM testing are negative in specimens collected 7 days to 12 weeks after symptom onset, recent infection with either virus is ruled out. 4

Confirmatory Testing When Needed

• Perform plaque reduction neutralization testing (PRNT) when IgM is positive without positive NAAT or NS1, or when definitive diagnosis is required for clinical or epidemiologic purposes (e.g., first case of local transmission, pregnancy, unusual clinical syndrome). 4, 1

• A PRNT titer ≥10 against dengue virus with negative PRNTs (<10) against Zika and other flaviviruses confirms recent dengue infection. 4, 1

• Document complete vaccination history for yellow fever, Japanese encephalitis, Zika, and other flavivirus vaccines, as these cause cross-reactive IgM results leading to false-positives. 4, 2

Clinical Assessment and Risk Stratification

Warning Signs Requiring Hospitalization

• Admit patients immediately if they exhibit any of the following warning signs: persistent vomiting preventing oral intake, severe abdominal pain, lethargy or restlessness, mucosal bleeding, rising hematocrit (>20% increase from baseline) with falling platelet count, or narrow pulse pressure ≤20 mmHg. 1, 2

• Hospitalize all patients with severe dengue manifestations: severe plasma leakage, severe bleeding, organ failure, or dengue shock syndrome (hypotension or narrow pulse pressure). 2

• Admit pregnant women with confirmed or suspected dengue due to increased risks of maternal death, hemorrhage, preeclampsia, and vertical transmission. 1, 2

• Hospitalize patients with comorbidities (diabetes, hypertension, heart disease, immunocompromised states) or those older than 60 years or younger than 1 year, as they have markedly higher risk of severe complications. 2

Outpatient Management Criteria

• Patients may be managed as outpatients only if they have no warning signs, no comorbidities, platelet count >100,000/mm³ without rapid decline, stable hematocrit without hemoconcentration, and reliable daily follow-up is available. 2

Laboratory Monitoring

• Order daily complete blood count to track platelet counts and hematocrit levels, monitoring for thrombocytopenia (platelets ≤100,000/mm³) and rising hematocrit as indicators of severe disease. 1, 2

• The absence of thrombocytopenia significantly reduces the probability of dengue (negative likelihood ratio 0.2), making it a useful rule-out finding. 1, 2

Management Principles

Fluid Management

• For patients without shock, ensure oral hydration exceeding 2,500 mL daily using oral rehydration solutions for moderate dehydration. 2

• For dengue shock syndrome, administer an initial fluid bolus of 20 mL/kg isotonic crystalloid over 5-10 minutes with immediate reassessment, and consider colloid solutions for severe shock with pulse pressure <10 mmHg. 2

Pain and Fever Management

• Use acetaminophen at standard doses for pain and fever relief; this is the only safe analgesic option in dengue. 2

• Never prescribe aspirin or NSAIDs when dengue cannot be excluded, as these medications dramatically increase bleeding risk. 2

Discharge Criteria

• Discharge patients when they meet all of the following criteria: afebrile for ≥48 hours without antipyretics, resolution or significant improvement of symptoms, stable hemodynamic parameters for ≥24 hours without support, adequate oral intake, urine output >0.5 mL/kg/hour in adults, and laboratory parameters returning to normal ranges. 2

• Instruct patients to monitor temperature twice daily and return immediately if fever rises to ≥38°C on two consecutive readings or if any warning signs develop. 2

Special Populations

Pregnant Women

• Test all pregnant women with both NAAT and serology for dengue and Zika virus, regardless of local outbreak patterns, due to the risk of adverse maternal and fetal outcomes. 1, 2

• Acetaminophen remains the safest analgesic option for pregnant women with dengue fever. 2

Elderly and Young Children

• Use the same diagnostic algorithm based on timing of presentation, but maintain a lower threshold for hospitalization and closer monitoring due to higher risk of severe complications. 1

Common Pitfalls to Avoid

• Do not assume a negative IgM test during the first few days of illness rules out dengue, as antibodies may not have developed yet; repeat testing after 5-7 days if clinical suspicion remains high. 4, 3

• Do not delay fluid resuscitation in patients showing signs of shock, as rapid intervention is critical to prevent mortality. 2

• Do not prescribe antibiotics empirically for dengue fever without evidence of bacterial co-infection, as bacterial co-infection occurs in less than 10% of cases and empiric antibiotics contribute to antimicrobial resistance. 2

• Do not interpret positive IgG alone as evidence of acute infection, as IgG antibodies persist for months to years after infection. 4, 3